<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="hwp">eLife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">08712</article-id><article-id pub-id-type="doi">10.7554/eLife.08712</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Cell Biology</subject></subj-group></article-categories><title-group><article-title>The GARP complex is required for cellular sphingolipid homeostasis</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-31886"><name><surname>Fröhlich</surname><given-names>Florian</given-names></name><aff><institution content-type="dept">Department of Genetics and Complex Diseases</institution>, <institution>Harvard T.H. Chan School of Public Health</institution>, <addr-line><named-content content-type="city">Boston</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-34379"><name><surname>Petit</surname><given-names>Constance</given-names></name><aff><institution content-type="dept">Department of Genetics and Complex Diseases</institution>, <institution>Harvard T.H. Chan School of Public Health</institution>, <addr-line><named-content content-type="city">Boston</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-34380"><name><surname>Kory</surname><given-names>Nora</given-names></name><aff><institution content-type="dept">Department of Genetics and Complex Diseases</institution>, <institution>Harvard T.H. Chan School of Public Health</institution>, <addr-line><named-content content-type="city">Boston</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-34381"><name><surname>Christiano</surname><given-names>Romain</given-names></name><aff><institution content-type="dept">Department of Genetics and Complex Diseases</institution>, <institution>Harvard T.H. Chan School of Public Health</institution>, <addr-line><named-content content-type="city">Boston</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-34382"><name><surname>Hannibal-Bach</surname><given-names>Hans-Kristian</given-names></name><aff><institution content-type="dept">Department of Biochemistry and Molecular Biology, VILLUM Center for Bioanalytical Sciences</institution>, <institution>University of Southern Denmark</institution>, <addr-line><named-content content-type="city">Odense</named-content></addr-line>, <country>Denmark</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-34383"><name><surname>Graham</surname><given-names>Morven</given-names></name><aff><institution content-type="dept">Center for Cellular and Molecular Imaging</institution>, <institution>Yale School of Medicine</institution>, <addr-line><named-content content-type="city">New Haven</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-15133"><name><surname>Liu</surname><given-names>Xinran</given-names></name><aff><institution content-type="dept">Center for Cellular and Molecular Imaging</institution>, <institution>Yale School of Medicine</institution>, <addr-line><named-content content-type="city">New Haven</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-4655"><name><surname>Ejsing</surname><given-names>Christer S</given-names></name><aff><institution content-type="dept">Department of Biochemistry and Molecular Biology, VILLUM Center for Bioanalytical Sciences</institution>, <institution>University of Southern Denmark</institution>, <addr-line><named-content content-type="city">Odense</named-content></addr-line>, <country>Denmark</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-34384"><name><surname>Farese</surname><given-names>Robert V</given-names></name><aff><institution content-type="dept">Department of Genetics and Complex Diseases</institution>, <institution>Harvard T.H. Chan School of Public Health</institution>, <addr-line><named-content content-type="city">Boston</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-8036"><name><surname>Walther</surname><given-names>Tobias C</given-names></name><aff><institution content-type="dept">Department of Genetics and Complex Diseases</institution>, <institution>Harvard T.H. Chan School of Public Health</institution>, <addr-line><named-content content-type="city">Boston</named-content></addr-line>, <country>United States</country><email>twalther@hsph.harvard.edu</email></aff><xref ref-type="fn" rid="conf1"/></contrib></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-1193"><name><surname>Tontonoz</surname><given-names>Peter</given-names></name><role>Reviewing editor</role><aff><institution>Howard Hughes Medical Institute, University of California, Los Angeles</institution>, <country>United States</country></aff></contrib></contrib-group><pub-date date-type="pub" publication-format="electronic"><day>10</day><month>09</month><year>2015</year></pub-date><volume>4</volume><elocation-id>e08712</elocation-id><supplementary-material><ext-link xlink:href="elife-08712-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material><history><date date-type="received"><day>14</day><month>05</month><year>2015</year></date><date date-type="accepted"><day>09</day><month>09</month><year>2015</year></date></history><permissions><copyright-statement>© 2015, Fröhlich et al</copyright-statement><copyright-year>2015</copyright-year><copyright-holder>Fröhlich et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><abstract><p>Sphingolipids are abundant membrane components and important signaling molecules in eukaryotic cells. Their levels and localization are tightly regulated. However, the mechanisms underlying this regulation remain largely unknown. Here, we identify the Golgi-associated retrograde protein (GARP) complex, which functions in endosome-to-Golgi retrograde vesicular transport, as a critical player in sphingolipid homeostasis. GARP deficiency leads to accumulation of sphingolipid synthesis intermediates, changes in sterol distribution and lysosomal dysfunction. A GARP complex mutation analogous to a <italic>VPS53</italic> allele causing progressive cerebello-cerebral atrophy type 2 (PCCA2) in humans exhibits similar, albeit weaker, phenotypes in yeast, providing mechanistic insights into disease pathogenesis. Inhibition of the first step of <italic>de novo</italic> sphingolipid synthesis is sufficient to mitigate many of the phenotypes of GARP-deficient yeast or mammalian cells. Together, these data show that GARP is essential for cellular sphingolipid homeostasis and suggest a therapeutic strategy for the treatment of PCCA2.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd><kwd><italic>S. cerevisiae</italic></kwd></kwd-group></article-meta></front><back><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf1"><p>The authors declare that no competing interests exist.</p></fn></fn-group></back></article>